Home > ABIRATERONE ACETATE
Abiraterone Acetate
This page provides concise information on the drug abiraterone acetate, including its indications, dosage and administration guidelines, mechanism of action, associated brands with their strengths, as well as important warnings and common side effects.
Background and Date of Approval
Abiraterone acetate, in conjunction with prednisone, received approval from the U.S. FDA on April 28, 2011, for the treatment of patients with metastatic castration-resistant prostate cancer who have undergone prior chemotherapy containing docetaxel.
Mechanism of Action of Abiraterone Acetate
Prostate cancer arises from an overproduction of male hormones (androgens/testosterone). Androgens are generated by the testicles, adrenal glands, and metastatic tumor. Abiraterone acetate functions by disrupting and inhibiting the enzyme CYP17A1, a catalyst in androgen production. This inhibition decreases the quantity of androgens synthesized in the body.
AVAILABLE BRANDS
ABIRATERONE ACETATE
Available Brands
Mytera 250mg Tablet
Mylan Pharmaceuticals Pvt Ltd
₹17990.26
Bdron 250mg Tablet
BDR Pharmaceuticals Intl Pvt
₹28440.26
Arbitus Tablet
Dr. Reddy's Laboratories Ltd
₹27650.26
Alkeprost 500mg Tablet
Alkem Laboratories Ltd
₹33300.26
Alkeprost 250mg Tablet
Alkem Laboratories Ltd
₹13999.00
Abritiga 250mg Tablet
Zee Laboratories Ltd
₹59990.00
Abretone 250mg Tablet
Premedium Pharmaceuticals P Ltd
₹28000.00
Abione 250mg Tablet
Intas Pharmaceuticals Ltd
₹30193.00
Biramet 250mg Tablet
Metta Life Sciences Private Limited
₹38000.00
Arbitus 250 mg Tablet
Dr. Reddys Laboratories Ltd.
₹15800.00
Shilrazone 250mg Tablet
Shilpa Medicare Ltd.
₹39999.00
Uniprost 250mg Tablet
Bangalore Pharmaceutical & Research Laboratory Ltd
₹35000.00
Xostiv 250mg Tablet
Abbott Healthcare Pvt Ltd
₹25000.00
Admatrone 250mg Tablet
Admac Life Sciences
₹27839.00
Xbira 250mg Tablet
Cipla Ltd
₹19500.00
Xbira 500mg Tablet
Cipla Ltd
₹22000.00
Abstet 250 MG Tablet
Biocon Limited
₹00.00
Adbiron 250mg Tablet
BDR Pharmaceuticals International Private Limited
₹38500.00
Zybiraa 250mg Tablet
Zydus Cadila
₹00.00
Abirapro 250mg Tablet
Glenmark Pharmaceuticals LtdZydus Cadila
₹39000.00
Zytiprost 250mg Tablet
Alkem Laboratories Ltd
₹9900.00
Abatitor 250mg Tablet
Torrent Pharma Ltd.
₹43949.00
Zytiga 250mg Tablet
Johnson & Johnson Pvt Ltd
₹150000.00
Abiratas 250mg Tablet
Intas Pharmaceuticals Ltd.
₹30193.00
Abiratas 250mg 30s Tablet
Intas Pharmaceuticals Ltd.
₹27700.00
Zecyte 250mg Tablet
Cipla Ltd
₹19500.00
Celbira 250mg Tablet
Celon Laboratories Ltd.
₹36000.00
Abiracure 250mg Tablet
Emcure Pharmaceuticals Ltd
₹29000.00
Ahabir 250mg Tablet
Hetero Healthcare Ltd
₹30000.00
Zelgor 250mg Tablet
Sun Pharmaceutical Industries Ltd
₹13000.00
Abitate 250mg Tablet
RPG Life Sciences Ltd
₹30000.00
Samtica 250mg Tablet
Samarth Life Sciences Pvt Ltd
₹29700.00
Avirat 250mg Tablet
Aureate Healthcare Pvt Ltd
₹39000.00
Abitate U 250mg Tablet
RPG Life Sciences Ltd
₹30000.00
Arbitus 500mg Tablet
Dr. Reddy's Laboratories Ltd
₹39500.00
Abiratred 500mg Tablet
Dr. Reddy's Laboratories Ltd
₹14000.00
Mytera 500mg Tablet
Mylan Pharmaceuticals Pvt Ltd
₹17990.00
Abiratas 500mg Tablet
Intas Pharmaceuticals Ltd
₹30193.00
Zelgor 500mg Tablet
Sun Pharmaceutical Industries Ltd
₹13000.00
Zecyte 500mg Tablet
Cipla Ltd
₹19500.00
Uses of Abiraterone Acetate
Abiraterone acetate is employed for the treatment of prostate cancer.
Abiraterone Acetate Drug administaration and Dosage available
Follow your doctor’s prescription when taking this medication. Abiraterone acetate is to be taken orally (by mouth), with the recommended dose being 1000mg (two tablets) once daily. Refrain from taking this medication with food, and ensure that the tablets are swallowed whole without breaking them.
Warnings, Precautions and Side Effects of Abiraterone Acetate
Warnings
Abiraterone acetate is unsafe during pregnancy as it may cause harm to the unborn baby. This medication must not be taken with food. If you are lactose intolerant inform your doctor before starting treatment with this medication as it contains lactose. Inform your doctor if you are on a salt control diet as it contains sodium.
Precautions
Notify your doctor of any pre-existing conditions such as liver disease, high blood pressure, heart failure, low blood potassium levels, and elevated sugar levels. Employ effective contraception during Abiraterone acetate treatment. Before initiating this medication, inform your doctor about any other medications you are currently taking.
Side Effects
Common adverse effects associated with Abiraterone acetate include bone fractures, indigestion, blood in the urine, rash, diarrhea, elevated levels of fat in the blood, chest pain, irregular heartbeat, rapid heart rate, urinary tract infection, fluid retention in the legs or feet, high blood pressure, and potentially severe low blood potassium levels in the body.
Word Of Advice
Abiraterone acetate should be taken once daily on an empty stomach, without any food. It is recommended to take the medication at least two hours after eating. After taking the medication, wait for at least one hour before consuming any food.
Frequently Asked Question
No, abiraterone acetate will not cure prostate cancer. However, it can help bettering and prolonging
the patient’s life.
Irregular heartbeat, rapid heart rate, urinary tract infection, fluid in the legs or feet, high BP, bone
fracture, indigestion, blood in urine, rash, diarrhea, high fat levels in the blood, chest pain, and low
blood potassium levels in the body (serious) are some common side effects of abiraterone
acetate.
If you miss a dose of abiraterone acetate, take the dose prescribed to you the next day. If you’ve
missed more than one dose then, consult your doctor.
Abiraterone acetate is to be taken orally. It must be swallowed as whole and must not be broken.
Abiraterone acetate is unsafe during pregnancy and must not be taken by women as it might cause
harm to the unborn baby. Men taking abiraterone acetate must follow effective contraceptive
measures.
References
- Centocor Ortho Biotech Inc, US Food and drug administration, [ Revised date: APR 2011] [ Accessed date: 26 MAY 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202379lbl.pdf
- Janssen- Cilag International NV, Electronics Medicine Compendium (emc), [Revised date: SEP 2021] [ Accessed date: 26 MAY 2022] https://www.medicines.org.uk/emc/files/pil.2381.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Natural products in cancer chemotherapy: hormones and related agents, 12th edition, 2011, 1707 – 1709.
Disclaimer
The drug information on this page is different from medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.